减重手术与结直肠病变发生风险降低独立相关
该研究回顾性分析了1985—2015年弗吉尼亚大学3,676例减重手术患者,并以46,873例肥胖非手术患者为对照进行1:1倾向评分匹配。匹配后4,462例(每组2,231例)中位随访7.8年,手术组新发结直肠病变为2.4% vs 4.8%(P < .0001),风险校正后减重手术与新发结直肠病变减少独立相关(OR 0.62,95% CI 0.42-0.91,P = .016)。
要点
- 减重手术组新发结直肠病变比例低于对照组(2.4% vs 4.8%)。
- 风险校正后减重手术与新发结直肠病变减少独立相关(OR 0.62)。
- 已发生结直肠癌者的息肉特征与分期在两组间无差异。
核心结论
- 在这一倾向评分匹配的大样本中,减重手术与风险校正后新发结直肠病变发生率较低相关。
- 结果提示减重手术的获益可能不限于减重和合并症改善。
研究设计与样本
- 单中心回顾性队列研究,纳入1985—2015年弗吉尼亚大学接受减重手术(胃旁路、袖状胃切除或胃束带)的患者3,676例。
- 对照组为机构数据仓库中肥胖非手术患者46,873例,按人口学、合并症、BMI及社会经济因素1:1倾向评分匹配。
- 匹配后共4,462例(每组2,231例),中位随访7.8年,采用单因素分析和条件logistic回归比较。
主要发现
- 匹配队列基线无统计学显著差异:初始BMI 48 vs 49 kg/m2,性别、年龄及其他合并症均P > .05。
- 手术组体重下降更多:超额BMI下降55.5% vs -1.4%,P < .0001。
- 手术组新发结直肠病变更少:2.4% vs 4.8%,P < .0001。
- 发生癌症者的息肉特征或分期在两组间无差异(均P > .05)。
- 风险校正后减重手术与新发结直肠病变减少独立相关(OR 0.62,95% CI 0.42-0.91,P = .016)。
临床怎么用
- 对肥胖患者评估减重手术指征时,可将降低结直肠病变风险的潜在获益纳入沟通。
- 减重术后仍应按常规结直肠癌筛查策略随访,本研究未评价筛查间隔变化。
局限性
- 为单中心回顾性研究,对照组来自机构数据仓库,可能存在选择与检测偏倚。
- 未报告结直肠病变的具体筛查方式与随访完整性,息肉特征与分期比较仅为探索性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity is a risk factor for colorectal cancer and possibly the formation of precancerous, colorectal polyps . Bariatric surgery is very effective for long-term weight loss; however, it is not known whether bariatric surgery decreases the risk of subsequent colonic neoplasia. We hypothesized that bariatric surgery would decrease the risk of developing colorectal lesions (new cancer and precancerous polyps). METHODS: We reviewed all patients (n = 3,676) who underwent bariatric surgery (gastric bypass, sleeve gastrectomy, or gastric banding) at the University of Virginia (Charlottesville, VA) 1985-2015. Obese, nonoperative patients (n = 46,873) from an institutional data repository were included as controls. Cases and controls were propensity score matched 1:1 by demographics, comorbidities, body mass index, and socioeconomic factors. The matched cohort was compared by univariate analysis and conditional logistic regression. RESULTS: A total of 4,462 patients (2,231 per group) with a median follow-up of 7.8 years were well-matched with no statistically significant baseline differences in initial body mass index (48 vs 49 kg/m2), sex, and age in addition to other comorbidities (all P > .05). The operative cohort had more weight loss (55.5% vs -1.4% decrease in excess body mass index, P < .0001). The operative cohort developed fewer colorectal lesions (2.4% vs 4.8%, P < .0001). We observed no differences in polyp characteristics or staging for patients who developed cancer (all P > .05). After risk adjustment, bariatric surgery was independently associated with a decrease in new colorectal lesions (OR 0.62, 95% CI 0.42-0.91, P = .016). CONCLUSION: Bariatric surgery was associated with lesser, risk-adjusted incidence of new colorectal lesions in this large population of propensity matched patients undergoing bariatric surgery compared with a control group not undergoing bariatric surgery. These results suggest the benefits of bariatric surgery may extend beyond weight loss and mitigation of comorbidities.
引用
- Kwak M, Mehaffey JH, Hawkins RB, et al. Bariatric surgery is independently associated with a decrease in the development of colorectal lesions. Surgery. 2019. PMID: 31097317. doi:10.1016/j.surg.2019.03.013
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。